Consideration of comorbidity in cancer treatment decision-making in multidisciplinary team meetings

the ONA take:

Comorbidity is very common among patients with cancer. Yet little is known about how comorbidity is factored into treatment decision making for these patients.

Treatment decisions are increasingly made within the context of multidisciplinary team meetings (MDTs). A systematic literature review was conducted to determine if and how comorbidity influences MDT decision-making.

The review included 21 original studies. Findings demonstrate that a lack of information on comorbidity impedes the ability to make treatment recommendations as well as to implement those recommendations.

Adjustments to recommended treatment due to comorbidity tends to result in a more conservative approach, despite evidence that treatments are tolerated and effective.

The review concludes that further research is needed to assist MDTs in appropriately addressing comorbidity in their treatment decisions, which can improve outcomes for cancer patients with comorbidities.

Doctors steer prostate cancer treatment choices
Little is known about how comorbidity is factored into treatment decision making for these patients.
Comorbidity is very common among patients with cancer. Multidisciplinary team meetings (MDTs) are increasingly the context within which cancer treatment decisions are made internationally. Little is known about how comorbidity is considered, or impacts decisions, in MDTs. MDTs should systematically consider treatment of patients with comorbidity.
READ FULL ARTICLE From Mdlinx
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs